Early-pregnancy sex steroid and thyroid function hormones, thyroid autoimmunity, and maternal papillary thyroid cancer incidence in the Finnish Maternity Cohort.

autoimmunity risk factors sex steroid hormones thyroid cancer thyroid function

Journal

International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124

Informations de publication

Date de publication:
02 May 2024
Historique:
revised: 02 04 2024
received: 10 12 2023
accepted: 09 04 2024
medline: 2 5 2024
pubmed: 2 5 2024
entrez: 2 5 2024
Statut: aheadofprint

Résumé

Thyroid cancer more commonly affects women than men and is the third most frequently diagnosed cancer among women of reproductive age. We conducted a nested case-control study within the Finnish Maternity Cohort to evaluate pre-diagnostic sex steroid and thyroid function markers in relation to subsequent maternal papillary thyroid cancer. Cases (n = 605) were women ages 18-44 years, who provided an early-pregnancy (<20 weeks gestation) blood sample and were diagnosed with papillary thyroid cancer up to 11 years afterward. Controls (n = 1185) were matched to cases 2:1 by gestational age, mother's age, and date at blood draw. Odds ratios (ORs) for the associations of serum thyroid peroxidase antibodies (TPO-Ab), thyroglobulin antibodies (Tg-Ab), thyroid stimulating hormone (TSH), free thyroxine (fT4), free triiodothyronine (fT3), progesterone, and estradiol with papillary thyroid cancer were estimated using conditional logistic regression. TPO-Ab and Tg-Ab positivity (>95th percentile among controls) were associated with more than 3-fold (OR = 3.32, 95% confidence interval [CI] 2.33-4.72) and 2-fold (OR = 2.03, 95% CI 1.41-2.93) increased odds of papillary thyroid cancer, respectively. These associations were similar by time since blood draw, parity, gestational age, smoking status, and age and stage at diagnosis. In models excluding TPO-Ab or Tg-Ab positivity, TPO-Ab (quartile 4 vs. 1: OR = 1.66, 95% CI 1.17-2.37, p-trend = .002) and Tg-Ab (quartile 4 vs. 1: OR = 1.74, 95% CI 1.22-2.49, p-trend = .01) levels were positively associated with papillary thyroid cancer. No associations were observed for estradiol, progesterone, TSH, fT3, or fT4 overall. Our results suggest that thyroid autoimmunity in early pregnancy may increase the risk of maternal papillary thyroid cancer.

Identifiants

pubmed: 38693841
doi: 10.1002/ijc.34974
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NCI NIH HHS
Pays : United States
Organisme : NIH HHS
Pays : United States

Informations de copyright

© 2024 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.

Références

Ferlay J, Ervik M, Lam F, et al. Global Cancer Observatory: Cancer Today. International Agency for Research on Cancer; 2020 Accessed June, 2023. https://gco.iarc.fr/today
Kitahara CM, Schneider AB. Epidemiology of thyroid cancer. Cancer Epidemiol Biomarkers Prev. 2022;31:1284‐1297.
O'Grady TJ, Rinaldi S, Michels KA, et al. Association of hormonal and reproductive factors with differentiated thyroid cancer risk in women: a pooled prospective cohort analysis. Int J Epidemiol. 2024;53:dyad172.
Troisi R, Bjørge T, Gissler M, et al. The role of pregnancy, perinatal factors and hormones in maternal cancer risk: a review of the evidence. J Intern Med. 2018;283:430‐445.
Vaccarella S, Franceschi S, Bray F, Wild CP, Plummer M, Dal Maso L. Worldwide thyroid‐cancer epidemic? The increasing impact of overdiagnosis. N Engl J Med. 2016;375:614‐617.
LeClair K, Bell KJL, Furuya‐Kanamori L, Doi SA, Francis DO, Davies L. Evaluation of gender inequity in thyroid cancer diagnosis: differences by sex in US thyroid cancer incidence compared with a meta‐analysis of subclinical thyroid cancer rates at autopsy. JAMA Intern Med. 2021;181:1351‐1358.
Andersson TM, Johansson AL, Fredriksson I, Lambe M. Cancer during pregnancy and the postpartum period: a population‐based study. Cancer. 2015;121:2072‐2077.
Zamora‐Ros R, Rinaldi S, Biessy C, et al. Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: the EPIC study. Int J Cancer. 2015;136:1218‐1227.
Horn‐Ross PL, Canchola AJ, Ma H, Reynolds P, Bernstein L. Hormonal factors and the risk of papillary thyroid cancer in the California teachers study cohort. Cancer Epidemiol Biomarkers Prev. 2011;20:1751‐1759.
Galofre JC, Davies TF. Autoimmune thyroid disease in pregnancy: a review. J Womens Health (Larchmt). 2009;18:1847‐1856.
Alexander EK, Pearce EN, Brent GA, et al. 2017 guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid. 2017;27:315‐389.
McLeod DS, Watters KF, Carpenter AD, Ladenson PW, Cooper DS, Ding EL. Thyrotropin and thyroid cancer diagnosis: a systematic review and dose‐response meta‐analysis. J Clin Endocrinol Metab. 2012;97:2682‐2692.
Moleti M, Sturniolo G, Di Mauro M, Russo M, Vermiglio F. Female reproductive factors and differentiated thyroid cancer. Front Endocrinol (Lausanne). 2017;8:111.
Nicolson NG, Brown TC, Korah R, Carling T. Immune cell infiltrate‐associated dysregulation of DNA repair machinery may predispose to papillary thyroid carcinogenesis. Surgery. 2020;167:66‐72.
Pukkala E, Andersen A, Berglund G, et al. Nordic biological specimen banks as basis for studies of cancer causes and control—more than 2 million sample donors, 25 million person years and 100,000 prospective cancers. Acta Oncol. 2007;46:286‐307.
Lehtinen M, Surcel HM, Natunen K, Pukkala E, Dillner J. Cancer registry follow‐up for 17 million person‐years of a nationwide maternity cohort. Cancer Med. 2017;6:3060‐3064.
Sund R. Quality of the Finnish hospital discharge register: a systematic review. Scand J Public Health. 2012;40:505‐515.
Fortner RT, Schock H, Kaaks R, et al. Early pregnancy sex steroids and maternal breast cancer: a nested case‐control study. Cancer Res. 2014;74:6958‐6967.
Schock H, Surcel HM, Zeleniuch‐Jacquotte A, et al. Early pregnancy sex steroids and maternal risk of epithelial ovarian cancer. Endocr Relat Cancer. 2014;21:831‐844.
Mӓnnistö T, Surcel HM, Bloigu A, et al. The effect of freezing, thawing, and short‐ and long‐term storage on serum thyrotropin, thyroid hormones, and thyroid autoantibodies: implications for analyzing samples stored in serum banks. Clin Chem. 2007;53:1986‐1987.
Holl K, Lundin E, Kaasila M, et al. Effect of long‐term storage on hormone measurements in samples from pregnant women: the experience of the Finnish Maternity Cohort. Acta Oncol. 2008;47:406‐412.
Reyna R, Traynor KD, Hines G, Boots LR, Azziz R. Repeated freezing and thawing does not generally alter assay results for several commonly studied reproductive hormones. Fertil Steril. 2001;76:823‐825.
Mӓnnistö T, Vaarasmaki M, Pouta A, et al. Perinatal outcome of children born to mothers with thyroid dysfunction or antibodies: a prospective population‐based cohort study. J Clin Endocrinol Metab. 2009;94:772‐799.
Toriola AT, Vӓӓrӓsmӓki M, Lehtinen M, et al. Determinants of maternal sex steroids during the first half of pregnancy. Obstet Gynecol. 2011;118:1029‐1036.
Nicholson WK, Robinson KA, Smallridge RC, Ladenson PW, Powe NR. Prevalence of postpartum thyroid dysfunction: a quantitative review. Thyroid. 2006;16:573‐582.
McLeod DSA, Bedno SA, Cooper DS, et al. Pre‐existing thyroid autoimmunity and risk of papillary thyroid cancer: a nested case‐control study of US active‐duty personnel. J Clin Oncol. 2022;40:2578‐2587.
Huang H, Rusiecki J, Zhao N, et al. Thyroid‐stimulating hormone, thyroid hormones, and risk of papillary thyroid cancer: a nested case‐control study. Cancer Epidemiol Biomarkers Prev. 2017;26:1209‐1218.
Rinaldi S, Plummer M, Biessy C, et al. Thyroid‐stimulating hormone, thyroglobulin, and thyroid hormones and risk of differentiated thyroid carcinoma: the EPIC study. J Natl Cancer Inst. 2014;106:dju097.
Schock H, Zeleniuch‐Jacquotte A, Lundin E, et al. Hormone concentrations throughout uncomplicated pregnancies: a longitudinal study. BMC Pregnancy Childbirth. 2016;16:146.

Auteurs

Cari M Kitahara (CM)

Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland, USA.

Heljä-Marja Surcel (HM)

Faculty of Medicine, University of Oulu, Oulu, Biobank Borealis of Northern Finland, Oulu, Finland.

Roni Falk (R)

Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland, USA.

Ruth M Pfeiffer (RM)

Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland, USA.

Tuija Männistö (T)

Nordlab, Oulu, Finland and Translational Medicine Research Unit, University of Oulu, Oulu, Finland.

Mika Gissler (M)

Department of Molecular Medicine and Surgery, Finnish Medical Birth Registry, Finnish Institute for Health and Welfare, Helsinki, Finland & Region Stockholm, Academic Primary Health Care Centre, Stockholm, Sweden & Karolinska Institutet, Stockholm, Sweden.

Britton Trabert (B)

Obstetrics and Gynecology Department, University of Utah School of Medicine, Huntsman Cancer Institute at the University of Utah, Salt Lake City, Utah, USA.

Classifications MeSH